Category: Disorders & Diseases

Disorders & Diseases

FDA Expands Casgevy for Children 2+ with Sickle Cell Disease

The FDA approved the first gene therapy for children as young as 2 years old with sickle cell disease or transfusion-dependent beta thalassemia.

Disorders & Diseases

DPP-1 Inhibitors Aim to Reduce Bronchiectasis Flare-Ups

A new class of drugs offers a disease-based approach to managing non-cystic fibrosis bronchiectasis by targeting airway inflammation.

Disorders & Diseases

Lung Cancer Survival Rates ‘Improving for Everyone,’ National Report Reveals

The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.

Chronic Pulmonary Disorders

CFTR Modulator Use Linked to Lower Anxiety in Children and Parents

New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.

Infectious Diseases

Monoclonal Antibody ‘Cocktail’ Protects Against Nipah and Hendra Viruses

The treatment combines two antibodies that attack the virus at different stages of infection, making it more difficult for the pathogens to develop resistance.

Critical Care

Remote Monitoring Fails to Reduce Readmissions After Sepsis, LRTI

Remote monitoring did not increase the time spent at home after discharge among patients hospitalized with sepsis or lower respiratory tract infection, according to results from a randomized clinical trial of 1,286 adults.

Cardiopulmonary & Thoracic

‘Robotic’ Lung Transplant Successful at Houston Hospital

The minimally invasive surgical approach may allow high-risk or frail patients to become candidates for lung transplantation.

Sleep Medicine

Monash, Brigham and Women’s Renew Sleep Research Partnership

The collaboration will focus on sleep and circadian medicine, including research into obstructive sleep apnea and wearable health technology.